Authors:
Kadish, AH
Buxton, AE
Kennedy, HL
Knight, BP
Mason, JW
Schuger, CD
Tracy, CM
Winters, WL
Boone, AW
Elnicki, M
Hirshfeld, JW
Lorell, BH
Rodgers, GP
Tracy, CM
Weitz, HH
Citation: Ah. Kadish et al., ACC/AHA clinical competence statement on electrocardiography and ambulatory electrocardiography - A report of the ACC/AHA/ACP-ASIM Task Force on Clinical Competence (ACC/AHA Committee to Develop a Clinical Competence Statement on Electrocardiography and Ambulatory Electrocardiography), J AM COL C, 38(7), 2001, pp. 2091-2100
Authors:
Pires, LA
Lehmann, MH
Buxton, AE
Hafley, GE
Lee, KL
Citation: La. Pires et al., Differences in inducibility and prognosis of in-hospital versus out-of-hospital identified nonsustained ventricular tachycardia in patients with coronary artery disease: Clinical and trial design implications, J AM COL C, 38(4), 2001, pp. 1156-1162
Authors:
Wyse, DG
Talajic, M
Hafley, GE
Buxton, AE
Mitchell, LB
Kus, TK
Packer, DL
Kou, WH
Lemery, R
Santucci, P
Grimes, D
Hickey, K
Stevens, C
Singh, SN
Citation: Dg. Wyse et al., Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): Drug testing and as-treated analysis, J AM COL C, 38(2), 2001, pp. 344-351
Citation: Mj. Weigner et Ae. Buxton, Nonsustained ventricular tachycardia - A guide to the clinical significance and management, MED CLIN NA, 85(2), 2001, pp. 305
Authors:
Gomes, JA
Cain, ME
Buxton, AE
Josephson, ME
Lee, KL
Hafley, GE
Citation: Ja. Gomes et al., Prediction of long-term outcomes by signal-averaged electrocardiography inpatients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction, CIRCULATION, 104(4), 2001, pp. 436-441
Authors:
Singh, SN
Karasik, P
Hafley, GE
Pieper, KS
Lee, KL
Wyse, DG
Buxton, AE
Citation: Sn. Singh et al., Electrophysiologic and clinical effects of angiotensin-converting enzyme inhibitors in patients with prior myocardial infarction, nonsustained ventricular tachycardia, and depressed left ventricular function, AM J CARD, 87(6), 2001, pp. 716-720
Citation: Ae. Buxton et Kl. Lee, Electrophysiologic testing to identify patients at risk for sudden death. Reply, N ENG J MED, 343(24), 2000, pp. 1813-1814
Authors:
Buxton, AE
Lee, KL
DiCarlo, L
Gold, MR
Greer, GS
Prystowsky, EN
O'Toole, MF
Tang, A
Fisher, JD
Coromilas, J
Talajic, M
Hafley, G
Citation: Ae. Buxton et al., Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death, N ENG J MED, 342(26), 2000, pp. 1937-1945
Citation: Me. Josephson et al., The role of the implantable cardioverter-defibrillator for prevention of sudden cardiac death, ANN INT MED, 133(11), 2000, pp. 901-910
Authors:
Buxton, AE
Lee, KL
Fisher, JD
Josephson, ME
Prystowsky, EN
Hafley, G
Citation: Ae. Buxton et al., A randomized study of the prevention of sudden death in patients with coronary artery disease, N ENG J MED, 341(25), 1999, pp. 1882-1890
Authors:
Buxton, AE
Hafley, GE
Lehmann, MH
Gold, M
O'Toole, M
Tang, A
Coromilas, J
Hook, B
Stamato, NJ
Lee, KL
Citation: Ae. Buxton et al., Prediction of sustained ventricular tachycardia inducible by programmed stimulation in patients with coronary artery disease - Utility of clinical variables, CIRCULATION, 99(14), 1999, pp. 1843-1850